Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands

被引：0
|
作者：
Elise R. A. Pennings
Müjde Durmaz
Otto Visser
Eduardus F. M. Posthuma
Djamila E. Issa
Martine E. D. Chamuleau
Pieternella J. Lugtenburg
Marie José Kersten
Avinash G. Dinmohamed
机构：
[1] Amsterdam UMC location University of Amsterdam,Department of Hematology
[2] Cancer Center Amsterdam,Erasmus School of Health Policy and Management
[3] LYMMCARE (Lymphoma and Myeloma Center Amsterdam),Department of Research and Development
[4] Erasmus University Rotterdam,Department of Registration
[5] Netherlands Comprehensive Cancer Organisation (IKNL),Department of Hematology
[6] Netherlands Comprehensive Cancer Organisation (IKNL),Department of Internal Medicine
[7] Leiden University Medical Center,Department of Internal Medicine
[8] Reinier de Graaf Gasthuis,Department of Hematology
[9] Jeroen Bosch Hospital,Department of Hematology
[10] Amsterdam UMC location Vrije Universiteit Amsterdam,Department of Public Health
[11] Erasmus MC Cancer Institute,undefined
[12] University Medical Center Rotterdam,undefined
[13] Erasmus MC,undefined
[14] University Medical Center Rotterdam,undefined
来源：
Blood Cancer Journal | / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands
    Pennings, Elise R. A.
    Durmaz, Mujde
    Visser, Otto
    Posthuma, Eduardus F. M.
    Issa, Djamila E.
    Chamuleau, Martine E. D.
    Lugtenburg, Pieternella J.
    Kersten, Marie Jose
    Dinmohamed, Avinash G.
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [2] Therapies and Outcomes for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Contemporary, Nationwide, Population-Based Study in the Netherlands
    Pennings, Elise R. A.
    Durmaz, Mujde
    Visser, Otto
    Posthuma, Eduardus F. M.
    Issa, Djamila E.
    Chamuleau, Martine E. D.
    Lugtenburg, Pieternella
    Kersten, Marie Jose
    Dinmohamed, Avinash G.
    BLOOD, 2022, 140 : 9564 - 9565
  • [3] Outcomes and Predictors of Survival for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Large Population-Based Analysis
    Gong, Inna
    Crump, Michael
    Prica, Anca
    Calzavara, Andrew
    Liu, Ning
    Rodin, Danielle
    Hodgson, David
    Mozessohn, Lee
    Cheung, Matthew C.
    Kuruvilla, John
    BLOOD, 2024, 144 : 3092 - 3093
  • [4] Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study
    Arboe, Bente
    Olsen, Maja Halgren
    Gorlov, Jette Sonderskov
    Duun-Henriksen, Anne Katrine
    Dalton, Susanne Oksbjerg
    Johansen, Christoffer
    Brown, Peter de Nully
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 207 - 216
  • [5] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [6] Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
    Salles, Gilles
    Dlugosz-Danecka, Monika
    Ghesquieres, Herve
    Jurczak, Wojciech
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 455 - 463
  • [7] Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysis
    Lee, Linda
    Crump, Michael
    Khor, Sara
    Hoch, Jeffrey S.
    Luo, Jin
    Bremner, Karen
    Krahn, Murray
    Hodgson, David C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (04) : 481 - 488
  • [8] Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study
    Ren, Liangliang
    Li, Ling
    Zhang, Lei
    Li, Xin
    Fu, Xiaorui
    Wang, Xinhua
    Wu, Jingjing
    Sun, Zhenchang
    Feng, Xiaoyan
    Chang, Yu
    Zhou, Zhiyuan
    Nan, Feifei
    Yan, Jiaqin
    Kong, Fei
    Zhang, Mingzhi
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (01) : 42 - 50
  • [9] Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden
    Harrysson, Sara
    Eloranta, Sandra
    Ekberg, Sara
    Enblad, Gunilla
    Jerkeman, Mats
    Hasselblom, Sverker
    Wahlin, Bjorn E.
    Andersson, Per-Ola
    Smedby, Karin E.
    BLOOD, 2018, 132
  • [10] Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study
    Liangliang Ren
    Ling Li
    Lei Zhang
    Xin Li
    Xiaorui Fu
    Xinhua Wang
    Jingjing Wu
    Zhenchang Sun
    Xiaoyan Feng
    Yu Chang
    Zhiyuan Zhou
    Feifei Nan
    Jiaqin Yan
    Fei Kong
    Mingzhi Zhang
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 42 - 50
12345